Go to Contents
Notice & News Targeting, Attacking, and Eradicating Cancers®

TOP

Notice & News

게시판
Regeneron and SillaJen Announce Immuno-Oncology Clinical Study Agreement for Combination Treatment in Kidney Cancer 2017-05-08